Politerapi Anti-Epilepsi pada Penderita Epilepsi Anak
DOI:
https://doi.org/10.55175/cdk.v47i3.350Keywords:
Anak, obat anti-epilepsi, politerapiAbstract
Epilepsi merupakan salah satu penyebab terbanyak morbiditas di bidang saraf anak, yang menimbulkan berbagai permasalahan antara lain kesulitan belajar, gangguan tumbuh-kembang, dan penurunan kualitas hidup anak. Prinsip pengobatan epilepsi dimulai dari monoterapi lini pertama menggunakan obat anti-epilepsi (OAE) berdasarkan jenis bangkitan. Kegagalan monoterapi berisiko menjadi epilepsi refrakter (intraktabel), sehingga perlu politerapi OAE.
Epilepsy is a common cause of morbidity in neuropediatric, causing various problems such as learning difficulties, growth disorders, and quality of life. Principles of epilepsy treatment are to start first-line anti-epileptic drug (AED) monotherapy according to seizure type. Monotherapy failure is a risk of becoming refractory epilepsy (intractable) AED polytherapy is needed.
Downloads
References
Aydin A, Ergor A, Ergor G, Dirik E. The prevalence of epilepsy amongst school children in Izmir, Turkey. Seizure 2002;11:392-6.
Harsono, Endang K, Suryani G. Pedoman tatalaksana epilepsi. 3rd Ed. Perdossi. 2006;62:1-43
DeBoer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy & Behavior. 2008;12:540 6.
Cavazos JE, Lum F, Spitz M. Seizure and epilepsy: Overview and classification. 2003.
Triono A, Herini ES. Faktor prognostik kegagalan terapi epilepsi pada anak dengan monoterapi. Universitas Gadjah Mada [Thesis]. Yogyakarta: Fakultas Kedokteran Universitas Gadjah Mada; 2014
Panayiotopoulos CP. The epilepsies seizure. Syndrome and management. London: Blondom Medical Publishing; 2005 .p. 1- 26
Mangunatmadja I, Handryastuti S, Risan NA, Epilepsi pada anak. Ikatan Dokter Anak Indonesia. 2016;1:5-6
Parton M, Cockerell C. Epilepsy the etiology and pathogenesis. Hospital Pharmacist. 2003;10:288 95.
Kusumastuti K, Gunadharma S, Kustiowati E. Pedoman tatalaksana epilepsi, kelompok studi epilepsi PERDOSSI. Surabaya: Airlangga University Press; 2014.
Fisher RS, Cros JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by international league againts epilepsy. Stanford Department of Neurology & Neurological Sciences. 2016 .p. 1-26
Vera R, Dewi MAR, Nursiah. Sindrom epilepsi pada anak. Palembang: Rumah sakit Moehammad Hoesin; 2014
Stafstrom CE. The pathophysiology of epileptic seizure: A primer for pediatricians. Pediatrics in Review. 1998;19(10):342 51.
Lazuardi S. Pengobatan epilepsi. In: Soetomenggolo TS, Ismael S, eds. Buku ajar neurologi anak. 2nd Ed. Jakarta; 2000. p. 226 41.
Benbadis SR, Tatum WO. Advances in the treatment of epilepsy. American Family Phisician. 2000;64(1):91 8.
Wibowo S, Gofir A. Penggunaan obat anti epilepsi dalam klinik. Yogyakarta: IP Saraf FK UGM; 2008
Mani J. Combination therapy in epilepsy: What, when, how and what not! J Assoc Physicians India. 2013;61(8 Suppl):40-4.
Schuele SU, Luders HO. Intractabel epilepsy: Management and therapeutic altenatives. Lancet Neurol. 2008;7:514-24.
Camfield P, Camfield C, Pohlmann-Eden B. Transition from pediatric to adult epilepsy care: A difficult process marked by medical and social crisis. American Epilepsy Society. 2012;12(4):13–21
Brigo F, Ausserer H, Tezzon F, Nardone R. When one plus one makes three: the quest for rational antiepileptic polytherapy with supraadditive anticonvulsant efficacy. Epilepsy Behav 2013;27:439–42.
Anderson M, Egunsola O, Cherrill J, Millward C, Fakis A, Choonara I, et al. A prospective study of adverse drug reactions to antiepileptic drugs in children. BMJ Open 2015;5:e008298.
Perucca E, Beghi E, Dulac O, Shorvon S, Tomson T. Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Res 2000;41:107–39.
Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacyand effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094–120.
Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013;54:551–63.
Utomo TY, Husni A, Hanum F. Pemberian fenitoin oral dan tmbulnya hiperplasia ginggiva pada pasien epilepsi. M Med Indones. 2011;45:200-5.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 2010;51:1069–77.
Egunsola O, Sammons HM, Whitehouse WP. Monotherapy or polytherapy for childhood epilepsies? Arch Dis Child. 2016;101:356-8
Ramzi, Yati S, Sunartini. Faktor prediktor epilepsi refrakter onset anak di awal terapi obat anti epilepsi Universitas Gadjah Mada [Thesis]. Yogyakarta: Fakultas Kedokteran Universitas Gadjah Mada; 2007
Malaysian Society of Neurosciences. Consensus guidelines on the management of epilepsy. Epilepsy Council; 2010.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
